Victory Capital Management
IMGN

Victory Capital Management’s Immunogen Inc IMGN Stock Holding History

Victory Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,213
Closed -$1.04M – 2612
2023
Q4 		$1.04M Sell
35,213
-105,633
-75% -$2.1M ﹤0.01% 1695
2023
Q3 		$2.24M Buy
140,846
+19,419
+16% +$323K ﹤0.01% 1355
2023
Q2 		$2.29M Buy
121,427
+96,353
+384% +$1.14M ﹤0.01% 1356
2023
Q1 		$96.3K Buy
25,074
+275
+1% +$1.17K ﹤0.01% 2361
2022
Q4 		$123K Sell
24,799
-11
-0% -$60 ﹤0.01% 2334
2022
Q3 		$119K Sell
24,810
-4,002
-14% -$21.1K ﹤0.01% 2448
2022
Q2 		$130K Sell
28,812
-507
-2% -$2.2K ﹤0.01% 2421
2022
Q1 		$142K Buy
29,319
+334
+1% +$1.85K ﹤0.01% 2465
2021
Q4 		$215K Buy
28,985
+750
+3% +$4.66K ﹤0.01% 2467
2021
Q3 		$160K Buy
28,235
+510
+2% +$2.95K ﹤0.01% 2561
2021
Q2 		$183K Sell
27,725
-2,446
-8% -$17.1K ﹤0.01% 2545
2021
Q1 		$244K Buy
30,171
+955
+3% +$7.8K ﹤0.01% 2474
2020
Q4 		$188K Buy
29,216
+3,411
+13% +$19.9K ﹤0.01% 2378
2020
Q3 		$93K Sell
25,805
-1,467
-5% -$5.92K ﹤0.01% 2350
2020
Q2 		$125K Sell
27,272
-29,464
-52% -$125K ﹤0.01% 2342
2020
Q1 		$194K Buy
56,736
+20,607
+57% +$90.1K ﹤0.01% 2338
2019
Q4 		$184K Buy
36,129
+11,092
+44% +$37.6K ﹤0.01% 2331
2019
Q3 		$61K Buy
+25,037
New +$66.5K ﹤0.01% 2596

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Victory Capital Management's IMGN Position: Q1 2024 in Review

Victory Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 35,213 shares — an estimated $1.04M sold.

Victory Capital Management first reported a position in IMGN in Q3 2019 and held it in 18 quarters. The position peaked at $2.29M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Victory Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Victory Capital Management sold 35,213 Immunogen Inc shares in Q1 2024, an estimated $1.04M.
  • Victory Capital Management first reported a position in Immunogen Inc in Q3 2019 and held it in 18 quarters.
  • Victory Capital Management's Immunogen Inc position peaked at $2.29M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Victory Capital Management's 13F filing for Q1 2024, filed 3 May 2024.